Keywords: Novartis, Lucentis, Nigeria, Cut price drugs, AMD

Novartis offers cut-price Lucentis to Nigeria to help in with AMD problems

Article | 19 April 2010

Print This

Swiss drug major Novartis is stepping in to help Nigeria cope with its growing incidence of age-related macular degeneration (AMD), ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in